RongChun Lin - DV Biomed Independent Director
| 6539 Stock | TWD 46.00 1.00 2.22% |
Insider
RongChun Lin is Independent Director of DV Biomed Co since 2019.
| Tenure | 5 years |
| Phone | 886 2 2791 1826 |
| Web | http://www.dvbiomed.com |
DV Biomed Management Efficiency
The company has return on total asset (ROA) of 8.85 % which means that it generated a profit of $8.85 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 23.52 %, meaning that it generated $23.52 on every $100 dollars invested by stockholders. DV Biomed's management efficiency ratios could be used to measure how well DV Biomed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mingyuan Zheng | TWOWAY Communications | N/A | |
| Wenyan Zhang | TWOWAY Communications | N/A | |
| ChunYung Huang | Chun Yuan Steel | N/A | |
| Yun Yuan | U Media Communications | N/A | |
| Leo Huang | TWOWAY Communications | N/A | |
| ShihChiang Hung | Sheng Yu Steel | N/A | |
| Shohei Kanzaki | Sheng Yu Steel | N/A | |
| JunXian Chao | Tung Ho Steel | N/A | |
| MingChi Chiang | Chun Yuan Steel | N/A | |
| YaChien Hsueh | Chunghwa Telecom Co | N/A | |
| Zhicheng Zhang | Tainet Communication System | N/A | |
| YoungChang Hsieh | Sheng Yu Steel | N/A | |
| Cangxiao Li | TWOWAY Communications | N/A | |
| ShihMin Hung | Chun Yuan Steel | N/A | |
| Xiao Liu | U Media Communications | N/A | |
| Zhong Huang | Tainet Communication System | N/A | |
| Guoyuan Dai | TWOWAY Communications | N/A | |
| JawChyuan Chu | TWOWAY Communications | N/A | |
| TungChin Lin | Sheng Yu Steel | 59 | |
| MingHsien Chen | Sheng Yu Steel | N/A | |
| RuYu He | Tung Ho Steel | N/A | |
Management Performance
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 |
DV Biomed Leadership Team
Elected by the shareholders, the DV Biomed's board of directors comprises two types of representatives: DV Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 6539. The board's role is to monitor DV Biomed's management team and ensure that shareholders' interests are well served. DV Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DV Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qunzhi Chen, Independent Director | ||
| Peter Hou, Independent Director | ||
| Xiumei Xie, Chief Financial Officer, Head of Finance | ||
| Liqi Zhang, Chairman of the Board, General Manager | ||
| RongChun Lin, Independent Director | ||
| Senxiong Zhang, Independent Director | ||
| Qingjun Huang, Deputy General Manager-Administration Division | ||
| Mingtong Chen, Director | ||
| Jiaqi Zhang, Director | ||
| Mingfeng He, Head of Finance & Accounting | ||
| Yiyun Li, Chief Operating Officer |
6539 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DV Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 | |||
| Profit Margin | 16.64 % | |||
| Operating Margin | 14.88 % | |||
| Current Valuation | 3.68 B | |||
| Shares Outstanding | 59.26 M | |||
| Price To Earning | 13.49 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 1.81 B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DV Biomed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DV Biomed's short interest history, or implied volatility extrapolated from DV Biomed options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DV Biomed Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for 6539 Stock analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |